GLP-1 Cost Effectiveness for Employer Sponsored Health Plans
CASE STUDY
How is your organization strategizing for the growth of GLP-1 utilization?
GLP-1 receptor agonists, or GLP-1 RAs, are changing the game for people living with Type 2 diabetes and obesity. These powerful medications, such as Ozempic, Trulicity, and Wegovy, not only help manage blood sugar levels but have also shown significant benefits in weight loss. However, due to their high cost and increasing demand, health plans and employers are facing challenges in providing coverage for these drugs.
While GLP-1 drugs offer undeniable health benefits, the financial strain on payers and the necessity of patient adherence to treatment plans underscore the complexity of incorporating these drugs into healthcare coverage.